Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026

2 hours ago 1
ARTICLE AD BOX
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.
Read Entire Article
  1. Homepage
  2. Finance
  3. Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026

Related

These 2 charts show why buying a house is the hardest it’s been in decades

These 2 charts show why buying a house is the hardest it’s b...

59 minutes ago 0
Oracle’s monster $25 billion debt financing points to anxieties around AI funding

Oracle’s monster $25 billion debt financing points to anxiet...

1 hour ago 0
Bye-bye, Bahama Breeze: Olive Garden parent gives up on restaurant chain after years of struggles

Bye-bye, Bahama Breeze: Olive Garden parent gives up on rest...

1 hour ago 0

Trending

1. uic
2. carlos santana mlb
3. lamine yamal
4. cmg stock
5. archie manning
6. charlotte mecklenburg schools
7. smci stock
8. amd earnings
9. tyler robinson
10. barca

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

11 months ago 530
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

11 months ago 494
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

10 months ago 467
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

11 months ago 410
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

11 months ago 362
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2026. All rights are reserved